Aurobindo Pharma USA, Inc. (“Aurobindo USA”), a wholly owned subsidiary of the Aurobindo Pharma Limited, earlier in this week had announced that it has received approval from the U.S. Federal...
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the official launch of its Lacosamide Injection USP, 200mg/mL,20mg/mL, 10mg/mL available in Single-Dose Vials, as detailed in the official...